Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 18;3(4):e00337-18.
doi: 10.1128/mSphere.00337-18.

Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones

Affiliations

Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones

Louise Roer et al. mSphere. .

Abstract

Escherichia coli sequence type 410 (ST410) has been reported worldwide as an extraintestinal pathogen associated with resistance to fluoroquinolones, third-generation cephalosporins, and carbapenems. In the present study, we investigated national epidemiology of ST410 E. coli isolates from Danish patients. Furthermore, E. coli ST410 was investigated in a global context to provide further insight into the acquisition of the carbapenemase genes blaOXA-181 and blaNDM-5 of this successful lineage. From 127 whole-genome-sequenced isolates, we reconstructed an evolutionary framework of E. coli ST410 which portrays the antimicrobial-resistant clades B2/H24R, B3/H24Rx, and B4/H24RxC. The B2/H24R and B3/H24Rx clades emerged around 1987, concurrently with the C1/H30R and C2/H30Rx clades in E. coli ST131. B3/H24Rx appears to have evolved by the acquisition of the extended-spectrum β-lactamase (ESBL)-encoding gene blaCTX-M-15 and an IncFII plasmid, encoding IncFIA and IncFIB. Around 2003, the carbapenem-resistant clade B4/H24RxC emerged when ST410 acquired an IncX3 plasmid carrying a blaOXA-181 carbapenemase gene. Around 2014, the clade B4/H24RxC acquired a second carbapenemase gene, blaNDM-5, on a conserved IncFII plasmid. From an epidemiological investigation of 49 E. coli ST410 isolates from Danish patients, we identified five possible regional outbreaks, of which one outbreak involved nine patients with blaOXA-181- and blaNDM-5-carrying B4/H24RxC isolates. The accumulated multidrug resistance in E. coli ST410 over the past two decades, together with its proven potential of transmission between patients, poses a high risk in clinical settings, and thus, E. coli ST410 should be considered a lineage with emerging "high-risk" clones, which should be monitored closely in the future.IMPORTANCE Extraintestinal pathogenic Escherichia coli (ExPEC) is the main cause of urinary tract infections and septicemia. Significant attention has been given to the ExPEC sequence type ST131, which has been categorized as a "high-risk" clone. High-risk clones are globally distributed clones associated with various antimicrobial resistance determinants, ease of transmission, persistence in hosts, and effective transmission between hosts. The high-risk clones have enhanced pathogenicity and cause severe and/or recurrent infections. We show that clones of the E. coli ST410 lineage persist and/or cause recurrent infections in humans, including bloodstream infections. We found evidence of ST410 being a highly resistant globally distributed lineage, capable of patient-to-patient transmission causing hospital outbreaks. Our analysis suggests that the ST410 lineage should be classified with the potential to cause new high-risk clones. Thus, with the clonal expansion over the past decades and increased antimicrobial resistance to last-resort treatment options, ST410 needs to be monitored prospectively.

Keywords: BEAST; Escherichia coli; epidemiology; evolution; high-risk clone; outbreak.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Rooted maximum likelihood phylogeny constructed with Gubbins based on SNP alignment of 49 Danish E. coli ST410 genomes. For each isolate, the following metadata are included: year of isolation, associated third-generation cephalosporin resistance (3GC resistance), and presence of IncFIA, IncFIB, IncFII, and IncX3 replicons. Possible clones and outbreaks are colored as per the key.
FIG 2
FIG 2
Introduction of OXA-181 and NDM-5 into E. coli ST410. Peaks in the density diagram are colored by the introduction of the carbapenemases: green, OXA-181; blue, NDM-5.
FIG 3
FIG 3
Time-scaled phylogeny of E. coli ST410 (n = 127) with associated third-generation cephalosporin resistance; plasmid replicons; mutations in the QRDR of gyrA, gyrB, parC, and parE; and the possible Danish outbreaks as colored by key. Brackets at right represent ST410 clades as described in the text. The tips of the tree to the left represent the year of isolation for the isolates, with the year stated next to the tips, which is colored by country of isolation, as per the key. ▲, genomes isolated from sources other than human. WT, wild type.

References

    1. Mathers AJ, Peirano G, Pitout JDD. 2015. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 28:565–591. doi:10.1128/CMR.00116-14. - DOI - PMC - PubMed
    1. Peirano G, Bradford PA, Kazmierczak KM, Badal RE, Hackel M, Hoban DJ, Pitout JDD. 2014. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis 20:1928–1931. doi:10.3201/eid2011.141388. - DOI - PMC - PubMed
    1. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4:e00377-13. doi:10.1128/mBio.00377-13. - DOI - PMC - PubMed
    1. Ben Zakour NL, Alsheikh-Hussain AS, Ashcroft MM, Khanh Nhu NT, Roberts LW, Stanton-Cook M, Schembri MA, Beatson SA. 2016. Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131. mBio 7:e00347-16. doi:10.1128/mBio.00347-16. - DOI - PMC - PubMed
    1. Schaufler K, Semmler T, Wieler LH, Wöhrmann M, Baddam R, Ahmed N, Müller K, Kola A, Fruth A, Ewers C, Guenther S. 2016. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410—another successful pandemic clone? FEMS Microbiol Ecol 92:fiv155. doi:10.1093/femsec/fiv155. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources